Salud financiera de hoja de balance de Mesa Laboratories
Salud financiera controles de criterios 1/6
Mesa Laboratories tiene un patrimonio de accionistas total de $403.0M y una deuda total de $233.0M, lo que sitúa su ratio deuda-patrimonio en 57.8%. Sus activos y pasivos totales son $741.8M y $338.8M respectivamente. El BAIT de Mesa Laboratories es de $1.4M, por lo que su ratio de cobertura de intereses es de 0.3. Tiene efectivo e inversiones a corto plazo que ascienden a $30.4M.
Información clave
57.8%
Ratio deuda-patrimonio
US$232.97m
Deuda
| Ratio de cobertura de intereses | 0.3x |
| Efectivo | US$30.37m |
| Patrimonio | US$402.96m |
| Total pasivo | US$338.81m |
| Activos totales | US$741.77m |
Actualizaciones recientes sobre salud financiera
Is Mesa Laboratories (NASDAQ:MLAB) Using Too Much Debt?
Mar 15
Is Mesa Laboratories (NASDAQ:MLAB) A Risky Investment?
Sep 28We Think Mesa Laboratories (NASDAQ:MLAB) Is Taking Some Risk With Its Debt
Jun 28Does Mesa Laboratories (NASDAQ:MLAB) Have A Healthy Balance Sheet?
Mar 13Does Mesa Laboratories (NASDAQ:MLAB) Have A Healthy Balance Sheet?
Aug 08We Think Mesa Laboratories (NASDAQ:MLAB) Can Stay On Top Of Its Debt
Dec 08Recent updates
Is Now An Opportune Moment To Examine Mesa Laboratories, Inc. (NASDAQ:MLAB)?
May 03Is Mesa Laboratories (NASDAQ:MLAB) Using Too Much Debt?
Mar 15Mesa Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Feb 08Is Mesa Laboratories, Inc. (NASDAQ:MLAB) Trading At A 43% Discount?
Dec 05Is Mesa Laboratories (NASDAQ:MLAB) A Risky Investment?
Sep 28Estimating The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)
Aug 09We Think Mesa Laboratories (NASDAQ:MLAB) Is Taking Some Risk With Its Debt
Jun 28Investor Optimism Abounds Mesa Laboratories, Inc. (NASDAQ:MLAB) But Growth Is Lacking
May 31A Look At The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)
Apr 12Does Mesa Laboratories (NASDAQ:MLAB) Have A Healthy Balance Sheet?
Mar 13Estimating The Fair Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)
Dec 20Mesa Laboratories declares $0.16 dividend
Oct 03Mesa Laboratories: Softening Bottom Line Fundamentals, Fairly Priced
Sep 09Are Investors Undervaluing Mesa Laboratories, Inc. (NASDAQ:MLAB) By 41%?
Sep 06Does Mesa Laboratories (NASDAQ:MLAB) Have A Healthy Balance Sheet?
Aug 08Mesa Laboratories GAAP EPS of -$0.27 misses by $0.27, revenue of $50.45M misses by $1.72M
Aug 04Mesa Laboratories declares $0.16 dividend
Jul 07A Look At The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)
May 06Growth Investors: Industry Analysts Just Upgraded Their Mesa Laboratories, Inc. (NASDAQ:MLAB) Revenue Forecasts By 14%
Apr 09We Think Mesa Laboratories (NASDAQ:MLAB) Can Stay On Top Of Its Debt
Dec 08Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($118.4M) de MLAB superan a sus pasivos a corto plazo ($44.2M).
Pasivo a largo plazo: Los activos a corto plazo ($118.4M) de MLAB no cubren sus pasivos a largo plazo ($294.6M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: La relación deuda neta-capital de MLAB (50.3%) se considera alta.
Reducción de la deuda: El ratio deuda-patrimonio de MLAB ha crecido de 27.2% a 57.8% en los últimos 5 años.
Cobertura de la deuda: La deuda de MLAB no está bien cubierta por el flujo de caja operativo (18.8%).
Cobertura de intereses: Los pagos de intereses de la deuda de MLAB no están bien cubiertos por el BAIT (0.3x cobertura).